Healthcare provider profile · identity verified

Christopher Sothoron Byrd, MD

Family Practice · HOLLY SPRINGS, NC · NPI 1619074804

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	682	214
Amlodipine Besylate	Amlodipine Besylate	549	172
Levothyroxine Sodium	Levothyroxine Sodium	370	98
Losartan Potassium	Losartan Potassium	301	91
Hydrochlorothiazide	Hydrochlorothiazide	285	95
Lisinopril	Lisinopril	282	95
Omeprazole	Omeprazole	255	74
Gabapentin	Gabapentin	235	82
Rosuvastatin Calcium	Rosuvastatin Calcium	226	74
Pravastatin Sodium	Pravastatin Sodium	215	60
Pantoprazole Sodium	Pantoprazole Sodium	206	66
Metoprolol Succinate	Metoprolol Succinate	191	59
Metformin Hcl	Metformin Hcl	186	61
Potassium Chloride	Potassium Chloride	177	52
Metformin Hcl Er	Metformin Hcl	166	50
Simvastatin	Simvastatin	154	41
Furosemide	Furosemide	143	49
Albuterol Sulfate Hfa	Albuterol Sulfate	141	61
Tamsulosin Hcl	Tamsulosin Hcl	137	40
Sertraline Hcl	Sertraline Hcl	125	45
Carvedilol	Carvedilol	122	28
Eliquis	Apixaban	119	34
Trazodone Hcl	Trazodone Hcl	114	46
Allopurinol	Allopurinol	101	29
Clopidogrel	Clopidogrel Bisulfate	89	27
Prednisone	Prednisone	88	70
Metoprolol Tartrate	Metoprolol Tartrate	87	26
Alprazolam	Alprazolam	86	27
Ibandronate Sodium	Ibandronate Sodium	86	24
Meloxicam	Meloxicam	84	39
Olmesartan Medoxomil	Olmesartan Medoxomil	81	19
Zolpidem Tartrate	Zolpidem Tartrate	79	25
Fluoxetine Hcl	Fluoxetine Hcl	77	19
Clonazepam	Clonazepam	76	16
Fluticasone Propionate	Fluticasone Propionate	69	33
Tramadol Hcl	Tramadol Hcl	69	23
Esomeprazole Magnesium	Esomeprazole Magnesium	66	14
Montelukast Sodium	Montelukast Sodium	65	23
Escitalopram Oxalate	Escitalopram Oxalate	64	27
Famotidine	Famotidine	58	21
Finasteride	Finasteride	56	17
Topiramate	Topiramate	56	suppressed
Duloxetine Hcl	Duloxetine Hcl	55	20
Celecoxib	Celecoxib	53	18
Citalopram Hbr	Citalopram Hydrobromide	53	13
Pregabalin	Pregabalin	53	15
Bupropion Xl	Bupropion Hcl	52	23
Lovastatin	Lovastatin	52	11
Ozempic	Semaglutide	52	suppressed
Glimepiride	Glimepiride	51	18
Venlafaxine Hcl Er	Venlafaxine Hcl	51	13
Ezetimibe	Ezetimibe	49	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	46	30
Synthroid	Levothyroxine Sodium	46	17
Diclofenac Sodium	Diclofenac Sodium	45	14
Lorazepam	Lorazepam	43	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	14
Pioglitazone Hcl	Pioglitazone Hcl	42	suppressed
Glipizide Er	Glipizide	41	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	36	17
Mirtazapine	Mirtazapine	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	13
Baclofen	Baclofen	33	13
Naproxen	Naproxen	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Spironolactone	Spironolactone	33	12
Valsartan	Valsartan	33	14
Januvia	Sitagliptin Phosphate	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	11
Amoxicillin	Amoxicillin	31	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	31	25
Atenolol	Atenolol	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Irbesartan	Irbesartan	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	13
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Ramipril	Ramipril	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Temazepam	Temazepam	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Colchicine	Colchicine	23	12
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Azithromycin	Azithromycin	21	19
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Estradiol	Estradiol	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Klor-Con M10	Potassium Chloride	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Primidone	Primidone	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Mupirocin	Mupirocin	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diazepam	Diazepam	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Testosterone	Testosterone	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Budesonide	Budesonide	13	suppressed
Glipizide	Glipizide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error